Approval · Notice of Compliance 10094 · 2009
NOROCLAV: Notice of Compliance 10094
Issued March 13, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10094
- Date
- March 13, 2009
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- CLAVAMOX TABLETS (Pfizer Canada Inc., Animal Health Group)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOROCLAV | 02323893 | Cancelled Post Market |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 300 MG per TAB
- CLAVULANATE POTASSIUM 75 MG per TAB